325 related articles for article (PubMed ID: 31161784)
1. Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway.
Nan L; Qin T; Xiao Y; Qian W; Li J; Wang Z; Ma J; Ma Q; Wu Z
Cell Transplant; 2019; 28(9-10):1289-1298. PubMed ID: 31161784
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21.
Yang XP; Liu SL; Xu JF; Cao SG; Li Y; Zhou YB
Exp Cell Res; 2017 Aug; 357(1):79-87. PubMed ID: 28461158
[TBL] [Abstract][Full Text] [Related]
3. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.
Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS
Carcinogenesis; 2014 Aug; 35(8):1891-900. PubMed ID: 24876152
[TBL] [Abstract][Full Text] [Related]
4. Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α.
Yan B; Jiang Z; Cheng L; Chen K; Zhou C; Sun L; Qian W; Li J; Cao J; Xu Q; Ma Q; Lei J
Exp Cell Res; 2018 Oct; 371(1):63-71. PubMed ID: 30056064
[TBL] [Abstract][Full Text] [Related]
5. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
Xu J; Liu S; Yang X; Cao S; Zhou Y
Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.
Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV
Br J Cancer; 2016 Feb; 114(3):269-80. PubMed ID: 26766740
[TBL] [Abstract][Full Text] [Related]
7. HGF/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR/NGF axis.
Qin T; Xiao Y; Qian W; Wang X; Gong M; Wang Q; An R; Han L; Duan W; Ma Q; Wang Z
Cell Death Dis; 2022 Apr; 13(4):387. PubMed ID: 35449152
[TBL] [Abstract][Full Text] [Related]
8. Targeting HGF/c-MET Axis in Pancreatic Cancer.
Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271944
[TBL] [Abstract][Full Text] [Related]
9. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer.
Li X; Wang Z; Ma Q; Xu Q; Liu H; Duan W; Lei J; Ma J; Wang X; Lv S; Han L; Li W; Guo J; Guo K; Zhang D; Wu E; Xie K
Clin Cancer Res; 2014 Aug; 20(16):4326-38. PubMed ID: 24947933
[TBL] [Abstract][Full Text] [Related]
10. Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis.
Xu Z; Pang TCY; Liu AC; Pothula SP; Mekapogu AR; Perera CJ; Murakami T; Goldstein D; Pirola RC; Wilson JS; Apte MV
Br J Cancer; 2020 May; 122(10):1486-1495. PubMed ID: 32203220
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53.
Liu WT; Jing YY; Yu GF; Chen H; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cell Cycle; 2016; 15(7):886-94. PubMed ID: 27077227
[TBL] [Abstract][Full Text] [Related]
12. NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway.
Jiang J; Bai J; Qin T; Wang Z; Han L
J Cell Mol Med; 2020 May; 24(10):5901-5910. PubMed ID: 32294802
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition.
Shi X; Wang M; Zhang Y; Guo X; Liu M; Zhou Z; Zhao Y; He R; Gao Y; Liu Y; Pan S; Zhou M; Zhao C; Yin T; Li X; Wang H; Yang J; Zhu F; Li M; Qin R
EBioMedicine; 2022 Dec; 86():104352. PubMed ID: 36371988
[TBL] [Abstract][Full Text] [Related]
15. Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer.
Sharma R; Malviya R
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188869. PubMed ID: 36842767
[TBL] [Abstract][Full Text] [Related]
16. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K
Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831
[TBL] [Abstract][Full Text] [Related]
17. High‑glucose microenvironment promotes perineural invasion of pancreatic cancer via activation of hypoxia inducible factor 1α.
Zhang L; Zhang W; Zhang X; Min Y; Zhao Y; Wang B; Li W; Mao S; Min W
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35088883
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells.
Bauer TW; Somcio RJ; Fan F; Liu W; Johnson M; Lesslie DP; Evans DB; Gallick GE; Ellis LM
Mol Cancer Ther; 2006 Jul; 5(7):1676-82. PubMed ID: 16891453
[TBL] [Abstract][Full Text] [Related]
19. HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis.
Mekapogu AR; Xu Z; Pothula S; Perera C; Pang T; Hosen SMZ; Damalanka V; Janetka J; Goldstein D; Pirola R; Wilson J; Apte M
Cancer Lett; 2023 Aug; 568():216286. PubMed ID: 37354984
[TBL] [Abstract][Full Text] [Related]
20. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
Vanderwerff BR; Church KJ; Kawas LH; Harding JW
Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]